ClinicalTrials.gg
Not yet recruitingNCT06661499Updated Oct 28, 2024

An Observational Clinical Study on the Construction of an Artificial Neural Network Model for ICU Pneumonia

An observational study in Pneumonia, sponsored by Chinese Medical Association. Not yet recruiting at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-10-28.

Sponsored by Chinese Medical Association · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
600
Ages
18 Years and older
Sex
All
01

Study summary

To achieve rapid, intelligent and accurate microbiological diagnosis and treatment for ICU pneumonia, an artificial neural network model for microbiological diagnosis is established, which depends on many clinical cases and machine deep learning from clinical experts' judgements according to species-specific rapid detection of pathogenic bacteria and other clinical parameter variables of patients.

Read the detailed description

This study is a prospective single-centre observational study, 600 ICU pneumonia patients are expected to be selected as the observation object, and the lower respiratory secretions of patients on d1, d3 and d7 after enrollment are collected for species-specific rapid detection and microbial culture, while the general information of the patients and the clinical information of the corresponding time points on d1, d3 and d7 are collected. Two experienced senior physicians were organized to determine whether the microbial results were colonized or infected, and an artificial neural network model for rapid and intelligent diagnosis of pathogenic microorganisms in ICU pneumonia will be established and validated through multi-dimensional machine learning.

02

Conditions studied

  • Pneumonia

Keywords

  • pneumonia
  • colonization
  • infection
  • artificial neural network model
  • intensive care unit
03

In context

Pneumonia

1,564 studies on the registry are indexed under Pneumonia; 265 are open to participants now.

This study's planned enrollment of 600 is above the median of 252 across 535 observational studies indexed under Pneumonia.

Browse Pneumonia studies →

Lead sponsor

Chinese Medical Association is the lead sponsor of 40 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Pneumonia patients who admitted to Nanjing Drum Tower Hospital from Jan 1,2025 to Dec 31,2027 and meet the inclusion criteria.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. aged ≥18 years;
  2. agreed to obtain lower respiratory specimens for rapid testing of pathogenic bacteria;
  3. all were enrolled by an experienced physician who dynamically determined that the microorganisms were in a colonised or infected state;
  4. signed an form.

Exclusion criteria

Exclusion Criteria:

  1. pregnant women;
  2. lactating women;
  3. patients who could not obtain lower respiratory specimens;
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
600 participants (estimated)
Patient registry
No

Interventions

  • Otherestablish an artificial neural network model

    to establish an artificial neural network model for pathogen diagnosis in ICU pneumonia

06

What researchers measure

Primary outcomes

  1. clinical evaluation of each microbial detected whether in colonization or infection

    Two experienced senior physicians are organized to determine whether the microbial are colonized or infected according to clinical values.

    Time frame: day1,day3 and day7 after enrollment

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 28, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06661499
Lead sponsor
Chinese Medical Association
Responsible party
Sponsor
First posted
Oct 28, 2024
Start date
Jan 2025 (estimated)
Primary completion
Dec 2027 (estimated)
Completion
Dec 2027 (estimated)
Last update
Oct 28, 2024

Study contacts

Yan Wang, Master
Contact
a_nengneng@163.com
+86 18905150275
Yan Wang, Master
principal investigator · Nanjing Drum Tower Hosptial

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion